Novel drug delivery strategies for porphyrins and porphyrin precursors
暂无分享,去创建一个
[1] H. Kato,et al. Pilot study of topical delivery of mono-L-aspartyl chlorin e6 (NPe6): implication of topical NPe6-photodynamic therapy. , 2003, Journal of pharmacological sciences.
[2] H. Wulf,et al. Photodynamic therapy of acne vulgaris using methyl aminolaevulinate: a blinded, randomized, controlled trial , 2006, The British journal of dermatology.
[3] Stanley B. Brown,et al. Photodynamic therapy and its applications in gynaecology , 1999, British journal of obstetrics and gynaecology.
[4] I. Stender,et al. Recalcitrant hand and foot warts successfully treated with photodynamic therapy with topical 5‐aminolaevulinic acid: a pilot study , 1999, Clinical and experimental dermatology.
[5] Michael R Hamblin,et al. A comparative in vitro photoinactivation study of clinical isolates of multidrug-resistant pathogens , 2007, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[6] Petras Juzenas,et al. Topical Application of 5-Aminolevulinic Acid and its Methylester, Hexylester and Octylester Derivatives: Considerations for Dosimetry in Mouse Skin Model¶ , 2002, Photochemistry and photobiology.
[7] P. McCarron,et al. Influence of solution viscosity and injection protocol on distribution patterns of jet injectors: application to photodynamic tumour targeting. , 2007, Journal of photochemistry and photobiology. B, Biology.
[8] N. Kollias,et al. Topical Drug Delivery in Humans with a Single Photomechanical Wave , 1999, Pharmaceutical Research.
[9] Norman J. James. Photoradiation therapy for cutaneous and subcutaneous malignancies , 1982 .
[10] J. W. van Dongen,et al. Photodynamic therapy with violet light and topical δ‐aminolaevulinic acid in the treatment of actinic keratosis, Bowen’s disease and basal cell carcinoma , 2001, Journal of the European Academy of Dermatology and Venereology : JEADV.
[11] G. Fabbrocini,et al. Photodynamic therapy with topical delta-aminolaevulinic acid for the treatment of plantar warts. , 2001, Journal of photochemistry and photobiology. B, Biology.
[12] Touqir Zahra,et al. Optical monitoring and treatment of potentially lethal wound infections in vivo. , 2003, Journal of Infectious Diseases.
[13] G. Andrews,et al. Stability of 5-aminolevulinic acid in novel non-aqueous gel and patch-type systems intended for topical application. , 2005, Journal of pharmaceutical sciences.
[14] G. Wettermark,et al. Photodynamic inactivation of verrucae vulgares. II. , 1977, Acta dermato-venereologica.
[15] J. Hadgraft,et al. Influence of lipophilic counter-ions in combination with phloretin and 6-ketocholestanol on the skin permeation of 5-aminolevulinic acid. , 2003, International journal of pharmaceutics.
[16] J Moan,et al. Build-up of esterified aminolevulinic-acid-derivative-induced porphyrin fluorescence in normal mouse skin. , 1996, Journal of Photochemistry and Photobiology. B: Biology.
[17] A. Moor,et al. Photodynamic treatment of adenoviral vectors with visible light: an easy and convenient method for viral inactivation , 1999, Gene Therapy.
[18] J. Moan,et al. Lipid cubic phases for improved topical drug delivery in photodynamic therapy. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[19] Johan Moan,et al. Topical Application of 5-Aminolevulinic Acid Hexyl Ester and 5-Aminolevulinic Acid to Normal Nude Mouse Skin: Differences in Protoporphyrin IX Fluorescence Kinetics and the Role of the Stratum Corneum¶ , 2000, Photochemistry and photobiology.
[20] Z. Malik,et al. Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins. , 1987, British Journal of Cancer.
[21] Henry,et al. Microfabricated microneedles: A novel approach to transdermal drug delivery , 1999, Journal of pharmaceutical sciences.
[22] J. H. Price,et al. Evaluation of a water-soluble bioadhesive patch for photodynamic therapy of vulval lesions. , 2005, International journal of pharmaceutics.
[23] C. Müller-Goymann,et al. Comparative permeation studies for delta-aminolevulinic acid and its n-butylester through stratum corneum and artificial skin constructs. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[24] J. P. Connelly,et al. Comparison of the Pharmacokinetics and Phototoxicity of Protoporphyrin IX Metabolized from 5‐Aminolevulinic Acid and Two Derivatives in Human Skin In Vivo ¶ , 2000, Photochemistry and photobiology.
[25] R. Law. “British National Formulary” , 1966 .
[26] Tayyaba Hasan,et al. Photodynamic therapy for Staphylococcus aureus infected burn wounds in mice , 2005, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[27] A. Tedesco,et al. Oleic Acid as Optimizer of the Skin Delivery of 5-Aminolevulinic Acid in Photodynamic Therapy , 2005, Pharmaceutical Research.
[28] S. Thibaut,et al. Potential efficacy of a delta 5-aminolevulinic acid thermosetting gel formulation for use in photodynamic therapy of lesions of the gastrointestinal tract. , 2002, Pharmacological research.
[29] S. Firdous,et al. Photodynamic therapy of non-melanoma skin cancers , 2011 .
[30] J. H. Price,et al. Successful photodynamic therapy of vulval Paget's disease using a novel patch‐based delivery system containing 5‐aminolevulinic acid , 2004, BJOG : an international journal of obstetrics and gynaecology.
[31] P. Hillemanns,et al. Topical 5‐aminolaevulinic acid‐photodynamic therapy for the treatment of urethral condylomata acuminata , 2004, The British journal of dermatology.
[32] Corona M. Cassidy,et al. Delivery of photosensitisers and light through mucus: investigations into the potential use of photodynamic therapy for treatment of Pseudomonas aeruginosa cystic fibrosis pulmonary infection. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[33] A. Wennberg,et al. Photodynamic therapy for acne vulgaris: a pilot study of the dose-response and mechanism of action. , 2007, Acta dermato-venereologica.
[34] M. Landthaler,et al. Topical 5-aminolevulinic acid for photodynamic therapy of basal cell carcinoma. Evaluation of stratum corneum permeability in vitro , 1996 .
[35] D. V. Ash,et al. Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. , 1994, British Journal of Cancer.
[36] B. W. Barry,et al. Novel mechanisms and devices to enable successful transdermal drug delivery. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[37] C. Valenta,et al. Skin permeation and stability studies of 5-aminolevulinic acid in a new gel and patch preparation. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[38] L. Visai,et al. Toluidine Blue-Mediated Photodynamic Effects on Staphylococcal Biofilms , 2007, Antimicrobial Agents and Chemotherapy.
[39] Petras Juzenas,et al. Microneedle-mediated intradermal delivery of 5-aminolevulinic acid: potential for enhanced topical photodynamic therapy. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[40] Samir Mitragotri,et al. Current status and future prospects of needle-free liquid jet injectors , 2006, Nature Reviews Drug Discovery.
[41] J. H. Price,et al. Phototoxicity of 5-Aminolevulinic Acid in the HeLa Cell Line as an Indicative Measure of Photodynamic Effect After Topical Administration to Gynecological Lesions of Intraepithelial Form , 2004, Pharmaceutical Research.
[42] G. Fabbrocini,et al. Photodynamic therapy with topical δ-aminolaevulinic acid for the treatment of plantar warts , 2001 .
[43] D. Salomon,et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. , 2002, Journal of the American Academy of Dermatology.
[44] G. Jori,et al. Zinc octa-n-alkyl phthalocyanines in photodynamic therapy: photophysical properties, accumulation and apoptosis in cell cultures, studies in erythrocytes and topical application to Balb/c mice skin , 2003, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[45] A. Tedesco,et al. Cubic phase gel as a drug delivery system for topical application of 5-ALA, its ester derivatives and m-THPC in photodynamic therapy (PDT). , 2003, Journal of photochemistry and photobiology. B, Biology.
[46] D. Kacerovská,et al. Genital warts treated by photodynamic therapy. , 2007, Skinmed.
[47] J. Moan,et al. Topical Bioadhesive Patch Systems Enhance Selectivity of Protoporphyrin IX Accumulation , 2006, Photochemistry and photobiology.
[48] R. Guy,et al. Iontophoretic Delivery of 5-Aminolevulinic Acid (ALA): Effect of pH , 2001, Pharmaceutical Research.
[49] James D. Campbell,et al. Needle-free vaccine delivery. , 2006, Advanced drug delivery reviews.
[50] Y. Chuang,et al. Bactericidal Effects of Toluidine Blue-Mediated Photodynamic Action on Vibrio vulnificus , 2005, Antimicrobial Agents and Chemotherapy.
[51] P. McCarron,et al. Design and evaluation of a water-soluble bioadhesive patch formulation for cutaneous delivery of 5-aminolevulinic acid to superficial neoplastic lesions. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[52] H. Gollnick,et al. Photodynamic Therapy in Dermatology , 2012 .
[53] M. Wainwright,et al. Photodynamic antimicrobial chemotherapy (PACT). , 1998, The Journal of antimicrobial chemotherapy.
[54] E. Tan,et al. Photodynamic therapy with 20% aminolevulinic acid for the treatment of recalcitrant viral warts in an Asian population , 2007, International journal of dermatology.
[55] Stanley B. Brown,et al. Comparative in vitro percutaneous penetration of 5‐aminolevulinic acid and two of its esters through excised hairless mouse skin , 2003, Lasers in surgery and medicine.
[56] Geoffrey Lee,et al. Self-adhesive thin films for topical delivery of 5-aminolevulinic acid. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[57] R. M. Szeimiesa,et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. , 2002 .
[58] R. Guy,et al. Transdermal delivery from a lipid sponge phase--iontophoretic and passive transport in vitro of 5-aminolevulinic acid and its methyl ester. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[59] L. Guillou,et al. ©1999 Cancer Research Campaign Article no. bjoc.1998.0338 , 2022 .
[60] A. Bruni,et al. The photodynamic effect of 5-(4-hydroxy-1-butinyl)-2,2′-bithienyl on dermatophytes , 1998 .
[61] B. Wren,et al. Killing of methicillin-resistant Staphylococcus aureus in vitro using aluminium disulphonated phthalocyanine, a light-activated antimicrobial agent. , 1997, The Journal of antimicrobial chemotherapy.
[62] Diarmaid J. Murphy,et al. In vitro phototoxicity of 5-aminolevulinic acid and its methyl ester and the influence of barrier properties on their release from a bioadhesive patch. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[63] J. P. Connelly,et al. A quantitative assessment of protoporphyrin IX metabolism and phototoxicity in human skin following dose‐controlled delivery of the prodrugs 5‐aminolaevulinic acid and 5‐aminolaevulinic acid‐n‐pentylester , 2001, The British journal of dermatology.
[64] Tayyaba Hasan,et al. Rapid Control of Wound Infections by Targeted Photodynamic Therapy Monitored by In Vivo Bioluminescence Imaging¶ , 2002 .
[65] V. von Felbert,et al. Photodynamic Therapy in the Treatment of Actinic Keratosis † , 2008, Photochemistry and photobiology.
[66] S. Engstrom,et al. Drug compatibility with the sponge phases formed in monoolein, water, and propylene glycol or poly(ethylene glycol). , 1998, Journal of pharmaceutical sciences.
[67] P. McCarron,et al. Antifungal photodynamic therapy. , 2008, Microbiological research.
[68] Henricus J C M Sterenborg,et al. Quantitative Model Calculation of the Time-dependent Protoporphyrin IX Concentration in Normal Human Epidermis After Delivery of ALA by Passive Topical Application or Iontophoresis¶ , 2002, Photochemistry and photobiology.
[69] P. McCarron,et al. Bioadhesive patch-based delivery of 5-aminolevulinic acid to the nail for photodynamic therapy of onychomycosis. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[70] C. Müller-Goymann,et al. The influence of topical formulations on the permeation of 5-aminolevulinic acid and its n-butyl ester through excised human stratum corneum. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[71] Faten Gad,et al. Targeted photodynamic therapy of established soft-tissue infections in mice , 2004 .
[72] C. Whitehurst,et al. Comparison of red and green light in the treatment of Bowen’s disease by photodynamic therapy , 2000, The British journal of dermatology.
[73] Q. Peng,et al. Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate. , 2001, Journal of photochemistry and photobiology. B, Biology.
[74] Christoph Abels,et al. Topical application of a first porphycene dye for photodynamic therapy – penetration studies in human perilesional skin and basal cell carcinoma , 1997, Archives of Dermatological Research.
[75] J. M. Marchetti,et al. In vitro skin permeation and retention of 5-aminolevulinic acid ester derivatives for photodynamic therapy. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[76] H. Wulf,et al. Photodynamic inactivation of virus warts: a controlled clinical trial , 1979, Clinical and experimental dermatology.
[77] J. V. van Lier,et al. Photodynamic inactivation of herpes viruses with phthalocyanine derivatives. , 1994, Journal of photochemistry and photobiology. B, Biology.
[78] D M Chilukuri,et al. Cubic phase gels as drug delivery systems. , 2001, Advanced drug delivery reviews.
[79] Sean P. Nair,et al. Development of a Novel Targeting System for Lethal Photosensitization of Antibiotic-Resistant Strains of Staphylococcus aureus , 2005, Antimicrobial Agents and Chemotherapy.
[80] M. Bentley,et al. Photodynamic Therapy of Skin Cancers: Sensitizers, Clinical Studies and Future Directives , 2000, Pharmaceutical Research.
[81] J. M. Marchetti,et al. A vehicle for photodynamic therapy of skin cancer: influence of dimethylsulphoxide on 5-aminolevulinic acid in vitro cutaneous permeation and in vivo protoporphyrin IX accumulation determined by confocal microscopy. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[82] Qian Peng,et al. Milestones in the development of photodynamic therapy and fluorescence diagnosis , 2007, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[83] M. Allen,et al. Lack of Pain Associated with Microfabricated Microneedles , 2001, Anesthesia and analgesia.
[84] C. Whitehurst,et al. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease , 1996, The British journal of dermatology.
[85] J. Moan,et al. Influence of formulation factors on methyl-ALA-induced protoporphyrin IX accumulation in vivo. , 2006, Photodiagnosis and photodynamic therapy.
[86] J. Kennedy,et al. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. , 1990, Journal of photochemistry and photobiology. B, Biology.
[87] R. Anderson,et al. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. , 2000, The Journal of investigative dermatology.
[88] J. Nelson,et al. Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. A pilot dose-ranging study. , 1997, Archives of dermatology.
[89] T. Roskams,et al. Effect of vehicles and esterification on the penetration and distribution of hypericin in the skin of hairless mice. , 2007, Photodiagnosis and photodynamic therapy.
[90] Z. Malik,et al. Herpes simplex virus proteins are damaged following photodynamic inactivation with phthalocyanines. , 1998, Journal of photochemistry and photobiology. B, Biology.
[91] Raymond Bonnett,et al. Physical and chemical studies related to the development of m-THPC (FOSCAN®) for the photodynamic therapy (PDT) of tumours , 2001 .
[92] Corona M. Cassidy,et al. Delivery of Methylene Blue and meso-tetra (N-methyl-4-pyridyl) porphine tetra tosylate from cross-linked poly(vinyl alcohol) hydrogels: a potential means of photodynamic therapy of infected wounds. , 2009, Journal of photochemistry and photobiology. B, Biology.
[93] A. Taub. Photodynamic therapy for the treatment of acne: a pilot study. , 2004, Journal of drugs in dermatology : JDD.
[94] Q. Peng,et al. Pharmacology of protoporphyrin IX in nude mice after application of ALA and ALA esters , 2003, International journal of cancer.